NAD+ IV Therapy Side Effects and Safety: What Boulder Patients Ask Before Booking

You have done the reading. You have heard the claims about energy, clarity, and cellular repair, and now, right before booking your first NAD+ IV session, one question keeps coming back, Is NAD safe, and what will it actually feel like?

That hesitation is completely normal. Sitting with an IV drip running is not a small decision, and wanting honest answers means you are approaching your health the right way. Plenty of people across Boulder, CO, and the Front Range are weighing the same question.

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every cell in the human body. Most NAD IV therapy side effects tend to be mild and fade within hours, and this guide covers what to know before you book.

What You Need to Know at a Glance

• Common side effects like nausea, flushing, and headaches tend to resolve within one to three hours.
• Infusion speed plays a role in how intense side effects feel, and slowing the drip may reduce discomfort.
• Pregnant individuals, those with liver conditions, and certain other groups should talk to a healthcare provider first.
• The quality and sourcing of the NAD+ product matter, and a medical setting with pharmaceutical-grade product may reduce risk.
• Human clinical evidence for injectable NAD+ is still developing, so realistic expectations and a qualified provider are important.

What Is NAD+ and Why Are People Getting IV Infusions?

NAD+ is involved in over 500 enzymatic reactions across the body, according to research published in Cell Metabolism, making it one of the most active coenzymes in human biology. Your cells use it for energy production, DNA repair, and cellular communication. The reported age-related decline of NAD+ in certain tissues is a big part of why supplementation has gained so much attention.

How Does NAD+ IV Therapy Differ From Oral Supplements?

Oral NAD+ supplements use precursors like nicotinamide riboside (NR) or nicotinamide mononucleotide (NMN), which your body converts into NAD+. An IV infusion delivers NAD+ directly into the bloodstream and bypasses digestion entirely, though most published human research has focused on oral precursors rather than direct IV NAD+.

A 2020 systematic review in Pharmaceuticals concluded that early results appear promising, though further clinical trials are needed to confirm benefits and compare delivery methods. When people ask whether NAD really works, the honest answer is that the science is still catching up, and outcomes may vary from person to person.

Is NAD+ IV Therapy Safe?

NAD+ is a molecule your body already produces and uses every day, which is why many providers consider it to have a generally favorable safety profile when administered under licensed medical supervision. Most people tolerate sessions well, and the side effects that do come up tend to be mild and temporary. A favorable safety profile does not mean risk-free for everyone, though, and knowing the common side effects and who should use extra caution can help you decide with confidence.

What Are the Most Common NAD+ IV Therapy Side Effects?

Most people who receive NAD+ IV infusions report mild, temporary reactions. Based on published clinical observations and provider reports, the most frequently noted side effects include:

• Nausea or stomach discomfort
• Flushing or a sensation of warmth
• Headaches
• Fatigue or lightheadedness
• Soreness, redness, or bruising at the injection site

How Long Do Side Effects Usually Last?

A 2026 retrospective pilot study published in Frontiers in Aging observed six adults who received 500 mg NAD+ IV infusions over four consecutive days. All six participants reported symptoms during the infusion, including nausea, abdominal cramping, diarrhea, and chest pressure, and the reactions stopped once the infusion ended. While that study was small, it aligns with the broader pattern reported by clinicians: most NAD+ IV side effects tend to fade within one to three hours.

Does Infusion Speed Affect How You Feel?

Yes, and most providers consider it one of the biggest variables. Faster drip rates tend to increase the intensity of symptoms like chest tightness, flushing, and nausea, while slowing the infusion may help significantly. Many clinics start with a slower rate and adjust based on how you respond.

Even so, slowing the drip is not a fix for every possible reaction, and a qualified provider should evaluate any symptom rather than simply adjusting the speed.

Are There Serious Risks to Know About?

Serious reactions are uncommon, yet anyone receiving a NAD+ infusion should know the warning signs that require attention. Some situations need emergency care, while others call for a prompt conversation with your provider.

Seek emergency care (call 911) if you notice:

• Trouble breathing or swelling of the face or throat
• Severe chest pain or pressure
• Fainting, confusion, or a seizure

Tell your provider right away if you experience:

• A rapid or irregular heartbeat that does not settle
• Persistent vomiting that does not stop after the infusion ends
• Signs of infection at the IV site, such as spreading redness, warmth, or drainage

What Has the FDA Said About NAD+ Product Quality?

The FDA has issued a public reminder that compounders should only use ingredients suitable for sterile drug preparation, and the agency specifically flagged cases where food-grade NAD+ was used to make intravenous products. Food-grade ingredients may carry a higher risk of contamination with microbes and endotoxins, and the FDA reported adverse events following use of certain NAD+ injectable products, including severe chills, shaking, vomiting, and fatigue.

Asking your provider about the sourcing and sterile compounding standards behind the NAD+ they use is a reasonable step before any session.

Who Should Be Cautious Before Trying NAD+ IV Therapy?

NAD+ IV infusions may not be right for everyone. Based on available clinical guidance, certain groups should consult a healthcare provider first:

• Pregnant or breastfeeding individuals
• Anyone with a history of cancer, since NAD+ plays a role in cellular metabolism and growth
• People with advanced liver or kidney disease
• Anyone on medications that affect liver metabolism
• Individuals with unstable cardiovascular conditions

What Does the Evidence Say About Whether NAD+ IV Therapy Works?

One of the most common questions people ask is whether IV nutrient therapy actually produces real results. The basic science behind NAD+ is well-established, and early clinical findings are encouraging, though larger human trials are still underway.

What Do Human Studies Show?

A 2019 pilot study followed eight participants during a six-hour infusion and mainly tracked how the molecule moved through the blood and urine rather than measuring clinical outcomes. The 2026 retrospective pilot in Frontiers in Aging compared IV NAD+ with IV nicotinamide riboside, though only six participants received NAD+, and a 2023 review in Advances in Nutrition evaluated NMN clinical trials and found acceptable short-term tolerability while noting that long-term data remain limited. Larger trials are expected to build on these early findings in the coming years.

What Does That Mean for You?

NAD+ IV therapy may offer potential benefits related to energy, cellular repair, and recovery support. The evidence base is still developing, so working with a qualified provider and setting realistic expectations can help you weigh the potential upside against the unknowns.

How Much Does NAD+ IV Therapy Typically Cost?

NAD IV therapy cost varies across the United States, with a single session generally ranging from $250 to $1,500 depending on dose, clinic, and formula. Most insurance plans do not cover NAD+ IV infusions, so asking about membership programs or payment plans ahead of time can help.

Questions Worth Asking Your Provider Before a Session

A few questions can go a long way before your first session:

• Where is the NAD+ compounded, and does the pharmacy follow sterile preparation standards?
• What dose and infusion speed will be used?
• What happens if symptoms develop during the session?
• Are baseline labs recommended before starting?

A provider at a medical clinic with proper oversight, such as a regenerative medicine or longevity-focused practice, can answer these directly.

Conclusion

NAD+ IV therapy continues to generate interest for its potential role in energy support, cellular health, and healthy aging. Side effects tend to be mild for most people, yet the quality of the product, the clinical setting, and the provider’s expertise all matter.

At Rocky Mountain Regenerative Medicine in Boulder, CO, NAD+ infusions use pharmaceutical-grade product and are administered by board-certified physicians who design individualized loading and maintenance schedules. NAD+ sessions can also be integrated into a broader longevity plan that may include hormone optimization, peptide therapy, hyperbaric oxygen therapy, comprehensive diagnostics, and the clinic’s Annual Membership Program.

Ready to learn whether NAD+ IV therapy may be a good fit for your health goals? Contact RMRM to ask questions or book an appointment to get started.

Disclaimer: The information in this article is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before considering any new therapy. Individual results may vary.

Sources

• FDA. “FDA Reminds Compounders to Use Ingredients Suitable for Sterile Compounding.” U.S. Food and Drug Administration. https://www.fda.gov/drugs/human-drug-compounding/fda-reminds-compounders-use-ingredients-suitable-sterile-compounding
• Reyna, K., et al. (2026). “Intravenous infusion of nicotinamide adenine dinucleotide (NAD+) versus nicotinamide riboside (NR): a retrospective tolerability pilot study in a real-world setting.” Frontiers in Aging. PMC12907335. https://pmc.ncbi.nlm.nih.gov/articles/PMC12907335/
• Grant, R., et al. (2019). “A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD+.” Frontiers in Aging Neuroscience. PMID: 31572171. https://pubmed.ncbi.nlm.nih.gov/31572171/
• Song, Q., et al. (2023). “The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update.” Advances in Nutrition. PMC10721522. https://pmc.ncbi.nlm.nih.gov/articles/PMC10721522/
• Radenkovic, D., Reason, Verdin, E. (2020). “Clinical Evidence for Targeting NAD Therapeutically.” Pharmaceuticals (Basel). PMID: 32942582. https://pubmed.ncbi.nlm.nih.gov/32942582